因为这并非是终极驳回,辉瑞仍然有劝服专利局再版布专利的机会。
Because it's not a final rejection, Pfizer still has an opportunity to persuade the Patent Office to reissue the patent.
纽约辉瑞在一月份就向专利局提交申请,望获得2011年的专利再版布,并在原始专利中修正一个“技术缺陷”。
New York-based Pfizer applied to the patent office in January to have the 2011 patent reissued, and to correct a "technical defect" in the original patent.
应用推荐